BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35661943)

  • 21. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach.
    Kiso M; Urabe Y; Ito M; Masuda K; Boda T; Kotachi T; Hata K; Yorita N; Nagasaki N; Abduwali M; Hiyama Y; Oka S; Tanaka S; Chayama K
    BMC Gastroenterol; 2020 Jul; 20(1):243. PubMed ID: 32727394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene.
    Sugimoto S; Yamada H; Takahashi M; Morohoshi Y; Yamaguchi N; Tsunoda Y; Hayashi H; Sugimura H; Komatsu H
    Gastric Cancer; 2014 Oct; 17(4):745-9. PubMed ID: 23812922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
    Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
    Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
    Foda AAM; Aziz AA; Mohamed MA
    Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
    Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
    World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
    Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
    Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
    Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
    J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
    van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
    Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.
    Oliveira C; de Bruin J; Nabais S; Ligtenberg M; Moutinho C; Nagengast FM; Seruca R; van Krieken H; Carneiro F
    Oncogene; 2004 Mar; 23(12):2236-40. PubMed ID: 14661064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
    Svrcek M
    Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
    [No Abstract]   [Full Text] [Related]  

  • 33. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma.
    Kim S; Ki CS; Kim KM; Lee MG; Kim S; Bae JM; Kim JW
    BMB Rep; 2011 Nov; 44(11):725-9. PubMed ID: 22118538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer.
    Tanis PJ; Ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
    Fu L; Yonemura A; Yasuda-Yoshihara N; Umemoto T; Zhang J; Yasuda T; Uchihara T; Akiyama T; Kitamura F; Yamashita K; Okamoto Y; Bu L; Wei F; Hu X; Liu Y; Ajani JA; Tan P; Baba H; Ishimoto T
    Gastric Cancer; 2022 May; 25(3):542-557. PubMed ID: 35166958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.